Age-related impairment in insulin release: The essential role of β 2-adrenergic receptor

Diabetes

Volumn 61, Issue 3, 2012, Pages 692-701

  Santulli, Gaetano ^a,b   Lombardi, Angela ^a,c   Sorriento, Daniela ^a   Anastasio, Antonio ^a   Del Giudice, Carmine ^a   Formisano, Pietro ^a   Béguinot, Francesco ^a   Trimarco, Bruno ^a   Miele, Claudia ^a   Iaccarino, Guido ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Columbia University ^*  (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GLUCOSE TRANSPORTER 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR PDX 1;

ADENOVIRUS; AGING; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; EX VIVO STUDY; GENE TRANSFER; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; IN VIVO STUDY; INSULIN RELEASE; INSULINOMA; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WILD TYPE;

AGE FACTORS; ANIMALS; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 2; HOMEODOMAIN PROTEINS; INSULIN; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; PPAR GAMMA; RECEPTORS, ADRENERGIC, BETA-2; TRANS-ACTIVATORS;

EID: 84857393446     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1027     Document Type: Article

References (50)

1. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009;58:773-795
2. Basu R, Breda E, Oberg AL, et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 2003;52:1738-1748 (Pubitemid 36792465)
3. Gumbiner B, Polonsky KS, Beltz WF, Wallace P, Brechtel G, Fink RI. Effects of aging on insulin secretion. Diabetes 1989;38:1549-1556 (Pubitemid 20006680)
4. Ma X, Becker D, Arena VC, Vicini P, Greenbaum C. The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysis. J Clin Endocrinol Metab 2009;94:2446-2451
5. Reaven E, Wright D, Mondon CE, Solomon R, Ho H, Reaven GM. Effect of age and diet on insulin secretion and insulin action in the rat. Diabetes 1983;32:175-180 (Pubitemid 13180352)
6. Perfetti R, Rafizadeh CM, Liotta AS, Egan JM. Age-dependent reduction in insulin secretion and insulin mRNA in isolated islets from rats. Am J Physiol 1995;269:E983-E990
7. Ihm SH, Matsumoto I, Sawada T, et al. Effect of donor age on function of isolated human islets. Diabetes 2006;55:1361-1368 (Pubitemid 44195375)
8. Iozzo P, Beck-Nielsen H, Laakso M, Smith U, Yki-Järvinen H, Ferrannini E; European Group for the Study of Insulin Resistance. Independent influence of age on basal insulin secretion in nondiabetic humans. J Clin Endocrinol Metab 1999;84:863-868 (Pubitemid 29138209)
9. Rosengren AH, Jokubka R, Tojjar D, et al. Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 2010;327:217-220
10. Doyle ME, Egan JM. Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev 2003;55:105-131 (Pubitemid 36268400)
11. Lembo G, Napoli R, Capaldo B, et al. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 1992;90:24-29
12. Seals DR, Esler MD. Human ageing and the sympathoadrenal system. J Physiol 2000;528:407-417
13. Lembo G, Capaldo B, Rendina V, et al. Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol 1994;266:E242-E247
14. Asensio C, Jimenez M, Kühne F, Rohner-Jeanrenaud F, Muzzin P. The lack of beta-adrenoceptors results in enhanced insulin sensitivity in mice exhibiting increased adiposity and glucose intolerance. Diabetes 2005;54:3490-3495 (Pubitemid 43334340)
15. Haffner CA, Kendall MJ. Metabolic effects of beta 2-agonists. J Clin Pharm Ther 1992;17:155-164
16. Ikarashi T, Hanyu O, Maruyama S, et al. Genotype Gly/Gly of the Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with elevated fasting serum insulin concentrations, but not with acute insulin response to glucose, in type 2 diabetic patients. Diabetes Res Clin Pract 2004;63:11-18 (Pubitemid 38018952)
17. Scarpace PJ, Mooradian AD, Morley JE. Age-associated decrease in beta-adrenergic receptors and adenylate cyclase activity in rat brown adipose tissue. J Gerontol 1988;43:B65-B70
18. Xiao RP, Tomhave ED, Wang DJ, et al. Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 1998;101:1273-1282 (Pubitemid 28145243)
19. Schocken DD, Roth GS. Reduced beta-adrenergic receptor concentrations in ageing man. Nature 1977;267:856-858 (Pubitemid 8110168)
20. Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJ. Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly. N Engl J Med 1984;310:815-819 (Pubitemid 14167761)
21. Bao X, Mills PJ, Rana BK, et al. Interactive effects of common beta2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function. Hypertension 2005;46:301-307 (Pubitemid 41099161)
22. Kang KB, Rajanayagam MA, van der Zypp A, Majewski H. A role for cyclooxygenase in aging-related changes of beta-adrenoceptor-mediated relaxation in rat aortas. Naunyn Schmiedebergs Arch Pharmacol 2007;375:273-281 (Pubitemid 46701626)
23. Ryall JG, Plant DR, Gregorevic P, Sillence MN, Lynch GS. Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats. J Physiol 2004;555:175-188 (Pubitemid 38313069)
24. White M, Roden R, Minobe W, et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 1994;90:1225-1238 (Pubitemid 24284444)
25. Chruscinski AJ, Rohrer DK, Schauble E, Desai KH, Bernstein D, Kobilka BK. Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem 1999;274:16694-16700
26. Evans-Molina C, Robbins RD, Kono T, et al. Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure. Mol Cell Biol 2009;29:2053-2067
27. Vigliotta G, Miele C, Santopietro S, et al. Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol Cell Biol 2004;24:5005-5015 (Pubitemid 38668062)
28. Santulli G, Basilicata MF, De Simone M, et al. Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit. J Transl Med 2011;9:7
29. Sorriento D, Santulli G, Fusco A, Anastasio A, Trimarco B, Iaccarino G. Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. Hypertension 2010;56:696-704
30. Xie T, Chen M, Zhang QH, Ma Z, Weinstein LS. Beta cell-specific deficiency of the stimulatory G protein alpha-subunit Gsalpha leads to reduced beta cell mass and insulin-deficient diabetes. Proc Natl Acad Sci USA 2007;104:19601-19606
31. Lombardi A, Ulianich L, Treglia AS, et al. Increased hexosamine biosynthetic pathway flux dedifferentiates INS-1E cells and murine islets by an extracellular signal-regulated kinase (ERK)1/2-mediated signal transmission pathway. Diabetologia 2012;55:141-153
32. Fiory F, Lombardi A, Miele C, Giudicelli J, Béguinot F, Van Obberghen E. Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia 2011;54:2941-2952
33. McGraw DW, Forbes SL, Mak JC, et al. Transgenic overexpression of beta (2)-adrenergic receptors in airway epithelial cells decreases bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 2000;279:L379-L389
34. Mutlu GM, Dumasius V, Burhop J, et al. Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling. Circ Res 2004;94:1091-1100 (Pubitemid 38579704)
35. 2-adrenoceptor gene transfer and role of NFκB and CREB transcription factors. Br J Pharmacol 2011;162:712-721
36. Iaccarino G, Ciccarelli M, Sorriento D, et al. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005;97:1182-1189
37. Sorriento D, Ciccarelli M, Santulli G, et al. The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. Proc Natl Acad Sci USA 2008;105:17818-17823
38. Perino A, Ghigo A, Ferrero E, et al. Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110g. Mol Cell 2011;42:84-95
39. Ciccarelli M, Santulli G, Campanile A, et al. Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. Br J Pharmacol 2008;153:936-946
40. Oriente F, Iovino S, Cassese A, et al. Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression. Diabetologia 2009;52:2642-2652
41. Mauvais-Jarvis F, Virkamaki A, Michael MD, et al. A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. Diabetes 2000;49:2126-2134
42. Faisy C, Pinto FM, Blouquit-Laye S, et al. beta2-Agonist modulates epithelial gene expression involved in the T- and B-cell chemotaxis and induces airway sensitization in human isolated bronchi. Pharmacol Res 2010;61:121-128
43. Blalock EM, Phelps JT, Pancani T, et al. Effects of long-term pioglitazone treatment on peripheral and central markers of aging. PLoS ONE 2010;5:e10405
44. Rosen ED, Kulkarni RN, Sarraf P, et al. Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis. Mol Cell Biol 2003;23:7222-7229 (Pubitemid 37214026)
45. Collins S, Yehuda-Shnaidman E, Wang H. Positive and negative control of Ucp1 gene transcription and the role of β-adrenergic signaling networks. Int J Obes (Lond) 2010;34(Suppl. 1):S28-S33
46. Fogli S, Pellegrini S, Adinolfi B, et al. Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscle. Br J Pharmacol 2011;162:378-391
47. 2-adrenergic receptor activation. Am J Physiol Endocrinol Metab 2011;300:E341-E349
48. Sung B, Park S, Yu BP, Chung HY. Modulation of PPAR in aging, inflammation, and calorie restriction. J Gerontol A Biol Sci Med Sci 2004;59:997-1006 (Pubitemid 39441788)
49. Guri AJ, Hontecillas R, Bassaganya-Riera J. Abscisic acid synergizes with rosiglitazone to improve glucose tolerance and down-modulate macrophage accumulation in adipose tissue: possible action of the cAMP/PKA/PPAR γ axis. Clin Nutr 2010;29:646-653
50. Kim SP, Ha JM, Yun SJ, et al. Transcriptional activation of peroxisome proliferator-activated receptor-gamma requires activation of both protein kinase A and Akt during adipocyte differentiation. Biochem Biophys Res Commun 2010;399:55-59